Biocryst Pharmaceuticals (BCRX) Gross Profit Growth (1y) (2013 - 2026)
Biocryst Pharmaceuticals (BCRX) Gross Profit Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | 2.43% |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | -8.36% |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | -5.56% |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | -3.83% |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | 9.27% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 38.19% |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | 11.92% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Biocryst Pharmaceuticals | 2.47 Bn | 2.11 Bn | 214.41 Mn | 33.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 33.54% |
| Mar 31, 2026 | 7.14% |
| Dec 31, 2025 | -107.03% |
| Sep 30, 2025 | 38.05% |
| Jun 30, 2025 | 49.17% |
| Mar 31, 2025 | 54.07% |
| Dec 31, 2024 | 36.58% |
| Sep 30, 2024 | 32.96% |
| Jun 30, 2024 | 31.91% |
| Mar 31, 2024 | 34.86% |
| Dec 31, 2023 | 19.03% |
| Sep 30, 2023 | 18.48% |
| Jun 30, 2023 | 24.98% |
| Mar 31, 2023 | 36.55% |
| Dec 31, 2022 | 65.09% |
| Sep 30, 2022 | 78.91% |
| Jun 30, 2022 | 31.46% |
| Mar 31, 2022 | 278.25% |
| Dec 31, 2021 | 1,073.49% |
| Sep 30, 2021 | 781.20% |